Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed ...
Posted on June 9, 2008 in Prescriptions (Category: Default)
\"Abstracts: LPV/SQV/r besides high-dose boosted IDV were not efficiently tolerated too led to <65% ITT virological aptitude windups. A randomized larger point pattern with new formulations together with/or additionally tolerable boosted PIs bounded by NNRTI-based bankruptcy is warranted.\"